OPTH

Optimi Health Corp

2.41

Oct 30 • 3:59 PM ET -0.19 (-7.31%)

2.50

Aftermarket • 4:15 PM ET +0.09 (3.73%)

Healthcare Drug Manufacturers - Specialty & Generic Canada Nano NASD

Peers: PBM OGI CRON TLRY CMPS CMND GHRS ENVB SILO SNDL

| Held by: PSIL

Scroll to Statements

Index	-
Market Cap	13.81M
Enterprise Value	8.23M
Income	-
Sales	-
Book/sh	2.17
Cash/sh	1.61
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	May 20, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.11
P/C	1.50
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	1.69
Current Ratio	1.73
Debt/Eq	0.29
LT Debt/Eq	0.01
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	27.91% -72.14%
Sales past 3/5Y	68.99% -
EPS Y/Y TTM	34.45%
Sales Y/Y TTM	-
EPS Q/Q	-842.19%
Sales Q/Q	137.27%
Earnings	Aug 14 BMO
EPS/Sales Surpr.	-43.14% -34.88%

Insider Own	18.98%
Insider Trans	0.00%
Inst Own	7.29%
Inst Trans	14.75%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-29.27%
SMA50	-43.31%
SMA200	-57.02%
Trades

Shs Outstand	5.73M
Shs Float	4.64M
Short Float	0.55%
Short Ratio	0.66
Short Interest	0.03M
52W High	8.84 -72.73%
52W Low	2.55 -5.49%
Volatility	9.37% 9.43%
ATR (14)	0.33
RSI (14)	18.33
Beta	1.31
Rel Volume	1.53
Avg Volume	38.84K
Volume	59,327

Perf Week	-25.85%
Perf Month	-48.06%
Perf Quarter	-50.31%
Perf Half Y	-67.87%
Perf YTD	-64.83%
Perf Year	-64.30%
Perf 3Y	-33.06%
Perf 5Y	-84.55%
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	2.60
Price	2.41
Change %	-7.31%

Oct-26-26 06:02PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
08:00AM	Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity (GlobeNewswire)
Oct-20-26 08:30AM	Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia (GlobeNewswire)
Oct-12-26 10:29AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -9.70%
Oct-07-26 09:00AM	Optimi Health to Present at the ThinkEquity Conference (GlobeNewswire)
07:30AM	Loading…
Sep-29-26 07:30AM	Optimi Health Appoints Melanie Pump to Board of Directors (GlobeNewswire)
Sep-23-26 09:00AM	Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply (GlobeNewswire)
Sep-22-26 09:00AM	Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer (GlobeNewswire)
Sep-21-26 11:01AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Sep-16-26 08:25AM	Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder (GlobeNewswire)
Sep-10-26 08:45AM	Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder (GlobeNewswire)
Sep-08-26 08:30AM	Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference (GlobeNewswire)
Aug-31-26 10:12AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Aug-17-26 03:26PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Aug-14-26 04:55PM	Optimi Health Establishes Discretionary Equity Facility (GlobeNewswire)
08:54AM	Loading…
Aug-10-26 08:54AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Jul-06-26 03:53PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Jun-29-26 11:13AM	Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression (PR Newswire) +8.80%
Jun-16-26 12:36PM	Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research (PR Newswire) -12.89%
Jun-15-26 11:28AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) +5.71%
Jun-10-26 02:24PM	Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial (PR Newswire)
Jun-08-26 02:41PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) +11.21%
12:54PM	Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development (PR Newswire)
Jun-02-26 07:30AM	Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia (GlobeNewswire)
May-29-26 03:30PM	Optimi Health (OPTH) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update (NewMediaWire) +5.58%
11:14AM	Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia (PR Newswire)
May-26-26 07:00AM	Optimi Health Advances Highest-Purity Natural Psilocybin Extract to Date (Newsfile Corp.)
May-21-26 01:42PM	SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public Heres What Aided The Decision (Stocktwits) -6.25%
01:07PM	Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering (Newsfile Corp.)
May-20-26 11:30AM	Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting (PR Newswire) -13.83%
08:00AM	Loading…
08:00AM	Optimi Health gibt Preisfestsetzung fur uberzeichnetes offentliches Angebot in Hohe von 15 Mio. US-$ und Nasdaq-Uplisting bekannt (Newsfile)

Show Previous News

Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. It offers formulation, active pharmaceutical ingredients (APIs), and drug product manufacturing from preclinical stages to analysis and commercial distribution and It also offers botanical psilocybin and MDMA. The company was founded on May 27, 2020 and is headquartered in Squamish, Canada.

Co-Founder & ChairmanMr. John James Wilson

Co-FounderMr. Dane Stevens

Co-FounderMr. Bryan Edward Safarik

Interim CFO & DirectorMr. Jacob Safarik

Chief Science OfficerDr. Preston A. Chase

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OPTH

Optimi Health Corp

Upgrade your Finviz experience